Merck Opens New Pharm Plant in Singapore, Plans Another

September 13, 2001 — SINGAPORE — Merck Sharp & Dohme has opened a $400 million manufacturing plant in Tuas and plans to spend another $100 million to build a new pharmaceutical facility in Singapore.

The Merck & Co. unit plans to use the newly-opened facility to produce active ingredients used in asthma and arthritis treatments. The plant is expected to account for one-tenth of the company’s total global output when production begins.

The facility is situated on a 30-acre site in the Tuas Biomediacal Park, which was developed by the Singapore government to bolster its status as a major life sciences center.

According to Merck officials, the second facility will be completed in 2003 and will bring the company’s workforce there to more than 250 people from 11 countries.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.